Colin Hislop, Chief Medical Officer at Anthera Pharmaceuticals Inc (ANTH), sold 12,500 shares at $5.31 ($66K) on 2015-11-13, disclosed to the SEC on 2015-11-18.
Scheduled sale ($66k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANTH | SELL | 2015-11-12 | $27K | — | Filing → |
| ANTH | SELL | 2012-02-06 | $246K | — | Filing → |
| ANTH | SELL | 2011-11-10 | $101K | — | Filing → |